Benzoyl peroxide is a highly lipophilic, oxidising agent with keratolytic and bacteriocidal effects. The effectiveness of benzoyl peroxide in the treatment of acne vulgaris is primarily attributable to its antibacterial activity, especially with respect to Propionibacterium acnes. Benzoyl peroxide is also believed to be effective in the treatment of acne on account of its anti-inflammatory and mild keratolytic properties.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Benzoyl peroxide is the active ingredient of these drugs:
Ireland United Kingdom
Germany Lithuania
Austria Germany
Canada Hong Kong Netherlands Spain
Canada
Austria Germany
Canada
Hong Kong Ireland
Germany
France
France
Cyprus
Spain
Spain
Brazil
Benzoyl peroxide is also found within below combination drugs:
ACANYA , ACNE PLUS , BENZACLIN , BENZAMYCIN , BENZOLAC-CL , CLINDOXYL , DUAC , EFFEZEL , EPIDUO , ERYBENZ , INDOXYL , NEUAC , ONEXTON , QUINODERM , TACTUPUMP
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):